ClinicalTrials.gov Identifier: NCT02632123

Study Locations as of March 6, 2018:  (Recruiting) London Health Science Centre, London, ON

Nebulized Fentanyl in Patients With Mild to Moderate Idiopathic Pulmonary Fibrosis and Chronic Dyspnea

ClinicalTrials.gov Identifier: NCT03018756

Study Locations as of January 12, 2018:  (Recruiting) Queen’s University, Kingston, ON

High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib (HOPE-IPF)

ClinicalTrials.gov Identifier: NCT02551068

Study Locations as of May 16, 2017:

(Recruiting) University of Alberta, Edmonton, AB; UBC Okanagan Kelowna, BC; St. Paul’s Hospital, Vancouver, BC; Queen’s University, Kingston, ON; McGill University, Montreal, QC; Laval University, Quebec City, QC

(Not yet recruiting) University of Calgary, Calgary, AB; McMaster University, Hamilton, ON

A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period

ClinicalTrials.gov Identifier: NCT03261037

Study Locations as of April 9, 2018:

(Recruiting) Hotel Dieu Hospital; Queen’s University; Department of Medicine, Kingston ON; Dr. Syed Anees Medicine Profession Corporation, Windsor, ON; Clinique de pneumologie et du sommeil de Lanaudiere, Saint-Charles-Borromee, QC

(Not yet recruiting) St. Clare’s Mercy Hospital, St. John’s, NL

Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Group 3 Pulmonary Hypertension

ClinicalTrials.gov Identifier: NCT02951429

Study Locations as of April 9, 2018: (Recruiting) CHUM Hôpital Notre-Dame, Montreal, QC; Hôpital Laval, Ste. Foy, QC

Efficacy and Safety of Nintedanib When Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment

ClinicalTrials.gov Identifier: NCT02802345

Study Locations as of February 14, 2018:  This study is active, but not recruiting participants.

ClinicalTrials.gov Identifier: NCT01619085

Study Locations as of March 5, 2018:  Study is active but not recruiting participants.

Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis

ClinicalTrials.gov Identifier: NCT01890265

Study Locations as of February 7, 2018:  This study is active but not recruiting participants.